ReviewNature reviews. Cancer2009
Targeting PI3K signalling in cancer: opportunities, challenges and limitations.
Jeffrey A EngelmanPubMed ↗Publisher ↗
No numbers read from the abstract.
1,233 papers cite itlatest 60 shown
this paperpooled ittrialcites it